Skip to content

Released Nov 9, 2016, before the open

10-Q filed Nov 9, 2016, 40 days after period end · 0001144204-16-132547

Q3 2016 · 10-Q
Revenue—
Net Income-$11.57MN/M vs Q3 2015N/M vs Q2 2016
EPS Diluted-$0.67N/M vs Q3 2015N/M vs Q2 2016
Operating Income-$11,678,925N/M
Operating Cash Flowderived-$7,864,320N/M
Free Cash Flowderived-$7,897,251N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2016Q3 2015Q3 2014Q3 2013
Net Income-$11.57M-$6.62M-$11.02M-$4.88M
EPS Diluted-$0.67-$0.38-$1.33-$1.23

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR